Notice of Issue. The Corporation will give written notice of and make all requisite filings respecting the issue of securities pursuant to the conversion of the Subscription Receipts, in such detail as may be required, to each securities commission, stock exchange, or similar regulatory authority in each jurisdiction in Canada in which there is legislation or regulations requiring the giving of any such notice in order that such issue of securities and the subsequent disposition of the securities so issued will not be subject to the prospectus requirements, if any, of such legislation or regulations.
Notice of Issue. The Corporation will give written notice of the issue of Common Shares pursuant to the exercise of any Warrants, in such detail as may be required, to each securities commission or similar regulatory authority in each jurisdiction in Canada in which there is legislation or regulations requiring the giving of any such notice in order that such issue of Common Shares and the subsequent disposition of the Common Shares so issued will not be subject to the prospectus requirements, if any, of such legislation or regulations.
Notice of Issue. If the Company proposes to issue any Equity Securities, then the Company shall give the Preemptive Investors written notice of its intentions, which notice shall describe the Equity Securities, the amount of Equity Securities the Company proposes to issue, and the price, terms and conditions upon which the Company proposes to issue such Equity Securities and shall offer such Equity Securities to the Preemptive Investors pursuant to the terms of this Section 4 (the “Initial Notice”).
Notice of Issue. The Company will give written notice of, and will make all necessary filings in respect of, the issue of the Underlying Securities pursuant to the conversion or deemed conversion of Special Warrants, in such detail as may be required, to any stock exchange upon which the Common Shares may be listed or to the securities regulatory authority in any of the Qualifying Jurisdictions if there is therein any applicable law, ruling or order requiring the giving of any such notice or the making of any such filings in order that the subsequent disposition of the Underlying Securities so issued will not be subject to the prospectus requirements of such applicable law, ruling or order (subject to any hold periods applicable to Underlying Securities issued pursuant to the conversion of Special Warrants prior to the Qualification Date).
Notice of Issue. If the Company proposes to issue any Equity Securities, then the Company shall give the Preemptive Investors written notice of its intentions, which notice shall describe the Equity Securities, the amount of Equity Securities the Company proposes to issue, and the price, terms and conditions upon which the Company proposes to issue such Equity Securities and shall offer such Equity Securities to the Preemptive Investors pursuant to the terms of this Section 4 (the “Initial Notice”). If the consideration to be paid for the Equity Securities is not cash, the fair market value of the consideration shall be determined in good faith by the Board and a reasonably detailed explanation of the Board’s determination of such value shall be included in the Initial Notice. All Preemptive Investors electing to participate in the offering of such Equity Securities shall pay the cash equivalent thereof as so determined.
Notice of Issue. If Customer encounters an Issue, Customer must sufficiently define the Issue in a written notice to Supplier. After receipt of written notice of an Issue from Customer, Supplier will notify Customer if Supplier cannot identify the cause of the Issue. If Supplier cannot identify the cause of the Issue, Customer will provide additional information regarding the Issue as Supplier may request in order to assist Supplier with identifying the cause of the Issue. Customer will provide a separate written notice for each Issue encountered by Customer. All notices pursuant to this SLA may be provided via email.
Notice of Issue. (a) No later than two Canadian Business Days prior to an Issue Date, the Issuer shall give to the Guarantor a notice in respect of Issue Advances that shall be made available to the Guarantor in connection with the relevant issuance, completed in the form attached hereto as Part A of Schedule 3 (an “Issue Notice”), setting out inter alia:
(i) The amount and currency of the proposed issue of each Tranche or Series of Covered Bonds under the Programme;
(ii) The principal amount and currency of the Issue Advances available for drawing on each Issue Advance Date in respect of Party B Initial Exchange Amounts, Party A Payment Amounts or Party B Final Exchange Amounts, on the Issue Date, each Interest Payment Date for such Tranche or Series, and in respect of payments of principal of the applicable Covered Bonds, including on or prior to the applicable Final Maturity Date, the principal amount and currency of the Issue Advance in respect of a redemption of a Series or Tranche on or prior to the applicable Final Maturity Date; and
(iii) The currency of each repayment of each Issue Advance.
(b) In the event the information in an Issue Notice requires an amendment due to more specific information being available on timing of an Issue Advance or the quantum of an Issue Advance, due to inter alia, a change of the date or dates on which Issue Advances are to be made in respect of Party B Initial Exchange Amounts, Party A Payment Amounts or Party B Final Exchange Amounts, the Issuer shall provide an amended Issue Notice, completed in the form attached hereto as Part B of Schedule 3, to the Guarantor no later than two Canadian Business Days prior to the relevant Drawdown Date for such Issue Advance.
Notice of Issue. If MediWound proposes to issue any Equity Securities in private offerings which are exempt from the registration requirements of the Securities Act, then MediWound shall give Mölnlycke written notice of its intentions, which notice shall describe the Equity Securities, the anticipated amount range of Equity Securities that MediWound proposes to issue, and the anticipated price range upon which MediWound proposes to issue such Equity Securities and shall offer such Equity Securities to Mölnlycke pursuant to the terms of this Section 8 (the “Initial Notice”).
Notice of Issue. Either party may give notice to the other of an Issue about the meaning or effect of the Contract, or about any matter arising under, out of or in any way connected with the Contract, within 28 days of becoming aware of the Issue. The parties must follow the Issue resolution procedure in clause 26.3 before either commences proceedings. If a party gives notice of an Issue under clause 26.1: RTA's authorised person and the Service Provider's authorised person must meet and acting in good faith, try to resolve the Issue quickly; if the Issue has not been resolved within 5 Business Days of the notice of Issue, the parties must refer the Issue to RTA's senior contract manager and the Service Provider's director of engineering who must meet and, acting in good faith try to resolve the Issue quickly; if the Issue has not been resolved within 10 Business Days of the notice of Issue, the parties must refer the Issue to RTA's regional manager and the Service Provider's General Manager who must meet and, acting in good faith try to resolve the Issue quickly. If the Issue has not been resolved within 20 Business Days of notice of Issue either party may commence proceedings. Notwithstanding the existence of an Issue, the Service Provider will continue to perform the Services under the Contract.
Notice of Issue. If:
(a) the Company proposes to issue any Securities other than in connection with the Listing; and
(b) approval has been given under clause 6.5(b)(12), the Company must give notice in writing to each Shareholder of the proposed issue specifying:
(c) the Offered Securities;
(d) the total number of Securities the Shareholder is entitled to purchase, being the Applicable Percentage of the Offered Securities; and
(e) the issue price of each Security.
